Want To Learn More About CPVS™?
HOW WE HELP COMPANIES
CAPITAL PLANNING VALUATION STRATEGY™
Capital Planning Valuation Strategy™ (CPVS™) is our proprietary 6-week process designed to help medtech, biotech, pharma, and life science business owners understand their business valuation in the market based on their due diligence, P&Ls, and balance sheets. We develop all important spread sheets for business management such as pro-forma capitalization table, pre- and post-valuation, deal comps analysis, pricing analysis, and cash flow projection. Learn more about how a CPVS™ can help your business unlock growth capital today.
Learn More About CPVS™DISRUPTION OF PRIVATE SECURITIES
The Democratization of Capital
Regulation A provides a vehicle for companies to raise up to $75 million per year from both accredited and non-accredited (“Main Street”) investors. This is made possible through the 2012 JOBS Act, which changed reporting and disclosure requirements for small and medium sized businesses.
Previously, they were restricted to either Venture Captial or onerous Regulation D offerings for growth capital. Regulation A provides capital-intensive life sciences companies with a viable alternative funding strategy. Read about the company that raised $60 million using Reg A+.
Industry Leading Partners
CPVS™ gives you an extensive network of partners to guide you through a successful Reg A Offering . You will have access to the legal, compliance, marketing, and technology resources from industry leaders.
Ready for CPVS™ Build-Out?
MedTech News
The latest on Regulation A , life sciences innovation, and the democritization of capital.
How to Choose the Right Funding Strategy for Your Startup
Whether you’re developing a revolutionary app or launching a groundbreaking product, having the right funding strategy is essential to fuel your growth and turn your ideas into reality. In this blog post, we will explore the various fundraising options available to startups and provide guidance on how to choose the one that best aligns with your business goals and objectives.
Read moreWhy do I need a FINRA Broker-Dealer?
Broker-dealers are an important element of the fundraising process, and selecting the right one is crucial to your success. Some states require issuers to work with a broker-dealer.
Read moreDigital Surgery 4.0 and The Power of Go, Go, Go
The LSI Blog features an interview with Scott Huennekens, the keynote speaker at the 2021 Emerging Medtech Summit, discussing his career, his “Go, go, go” philosophy.
Read more